Continuous or modulation expression of hematopoietic cell antigens in sublines of the leukemia cell line, K-562. 1987

A T Ichiki, and C B Lozzio, and E G Bamberger, and P B Lucas, and C J Wust, and J E Fuhr

K-562 is described as a pluripotent leukemic cell line which expresses a diversity of hematopoietic cell differentiation antigens. With the use of monoclonal antibodies (MoAb), we show that the expression of these antigens is either "modulated", i.e. they are not expressed in early logarithmic growth but are expressed in late logarithmic growth, or "continuous", i.e. they are not affected by proliferation and phase of culture growth. Whether an antigen is modulated or continuously expressed appears to be an inherent property of the subline, since the expression of myeloid antigen binding the MoAb, PM81, was modulated on cells from a clone, whereas, the expression of this antigen was continuous by the parent subline and an independent subline F-1. Continuously expressed antigens appear to be an integral component of the K-562 cell surface matrix, while modulated antigen expression appears to be influenced by culture growth conditions.

UI MeSH Term Description Entries
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D001752 Blast Crisis An advanced phase of chronic myelogenous leukemia, characterized by a rapid increase in the proportion of immature white blood cells (blasts) in the blood and bone marrow to greater than 30%. Blast Phase,Blast Crises,Blast Phases,Crises, Blast,Crisis, Blast,Phase, Blast,Phases, Blast
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006412 Hematopoietic Stem Cells Progenitor cells from which all blood cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood. Colony-Forming Units, Hematopoietic,Progenitor Cells, Hematopoietic,Stem Cells, Hematopoietic,Hematopoietic Progenitor Cells,Cell, Hematopoietic Progenitor,Cell, Hematopoietic Stem,Cells, Hematopoietic Progenitor,Cells, Hematopoietic Stem,Colony Forming Units, Hematopoietic,Colony-Forming Unit, Hematopoietic,Hematopoietic Colony-Forming Unit,Hematopoietic Colony-Forming Units,Hematopoietic Progenitor Cell,Hematopoietic Stem Cell,Progenitor Cell, Hematopoietic,Stem Cell, Hematopoietic,Unit, Hematopoietic Colony-Forming,Units, Hematopoietic Colony-Forming
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

A T Ichiki, and C B Lozzio, and E G Bamberger, and P B Lucas, and C J Wust, and J E Fuhr
November 1983, Cancer research,
A T Ichiki, and C B Lozzio, and E G Bamberger, and P B Lucas, and C J Wust, and J E Fuhr
February 2009, Leukemia research,
A T Ichiki, and C B Lozzio, and E G Bamberger, and P B Lucas, and C J Wust, and J E Fuhr
January 1982, Birth defects original article series,
A T Ichiki, and C B Lozzio, and E G Bamberger, and P B Lucas, and C J Wust, and J E Fuhr
January 1985, Archiv fur Geschwulstforschung,
A T Ichiki, and C B Lozzio, and E G Bamberger, and P B Lucas, and C J Wust, and J E Fuhr
September 1984, Cancer research,
A T Ichiki, and C B Lozzio, and E G Bamberger, and P B Lucas, and C J Wust, and J E Fuhr
April 1981, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
A T Ichiki, and C B Lozzio, and E G Bamberger, and P B Lucas, and C J Wust, and J E Fuhr
January 2005, Neoplasma,
A T Ichiki, and C B Lozzio, and E G Bamberger, and P B Lucas, and C J Wust, and J E Fuhr
December 1977, Journal of the National Cancer Institute,
A T Ichiki, and C B Lozzio, and E G Bamberger, and P B Lucas, and C J Wust, and J E Fuhr
January 1979, Leukemia research,
A T Ichiki, and C B Lozzio, and E G Bamberger, and P B Lucas, and C J Wust, and J E Fuhr
April 1983, Experientia,
Copied contents to your clipboard!